Drugs / JM-4
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT03887065 | Jun → Dec 2019 | multiple sclerosis | Cook, Stuart, MD | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JM-4 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03887065 ↗ |
| Modality | Peptide | “Novel small human peptide derived from erythropoietin” NCT03887065 ↗ |
| Route | Intravenous | “via intravenous infusion” NCT03887065 ↗ |